Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
13.42
-0.01 (-0.07%)
Jul 30, 2026, 2:46 PM EDT - Market open
Biohaven Market Cap
Biohaven has a market cap or net worth of $2.02 billion as of July 30, 2026. Its market cap has increased by 54.23% in one year.
Market Cap
2.02B
Enterprise Value
1.94B
1-Year Change
54.23%
Ranking
Category
Stock Price
$13.42
ChartMarket Cap Chart
Since September 23, 2022, Biohaven's market cap has increased from $261.58M to $2.02B, an increase of 672.44%. That is a compound annual growth rate of 70.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 2.02B | 34.88% |
| Dec 31, 2025 | 1.50B | -60.34% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 261.68% |
| Sep 23, 2022 | 261.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agios Pharmaceuticals | 2.08B |
| Harmony Biosciences Holdings | 2.08B |
| Zai Lab | 2.06B |
| Palvella Therapeutics | 2.05B |
| Iovance Biotherapeutics | 2.04B |
| Sionna Therapeutics | 2.02B |
| ADMA Biologics | 2.02B |
| SELLAS Life Sciences Group | 1.99B |